DCF — HACKENSACK UNIVERSITY MEDICAL CENTER
Enterprise Value: $-1.1B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.1B
Enterprise Value
$-386.1M
PV of Cash Flows
$-687.2M
PV of Terminal Value
$-1.1B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $2.1B | $-41.5M | -2.0% | $-128.5M | $-116.8M |
| Year 2 | $2.1B | $-21.5M | -1.0% | $-111.2M | $-91.9M |
| Year 3 | $2.2B | $-0.4M | -0.0% | $-92.7M | $-69.6M |
| Year 4 | $2.2B | $10.9M | 0.0% | $-84.2M | $-57.5M |
| Year 5 | $2.3B | $17.0M | 1.0% | $-81.0M | $-50.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.1B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$2.0B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.025166748634140864
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5